Postoperative Treatment Regimens in Patients With Native Valve Endocarditis due to <i>Staphylococcus aureus</i> Who Undergo Valve Replacement or Repair
Among patients treated for native valve infective endocarditis caused by <i>S aureus</i> after valvular surgical intervention, all study outcomes-adverse events and drug-drug interactions, 6-month infective endocarditis relapse, and 1-year mortality-were higher in the combination therapy group than the monotherapy group.
Authors
- John Charles O’Horo (ORCID: https://orcid.org/0000-0002-0880-4498)
- Silpita Katragadda (ORCID: https://orcid.org/0000-0003-2065-2586)
- Daniel Christopher DeSimone (ORCID: https://orcid.org/0000-0002-9441-0283)
- Brian D. Lahr (ORCID: https://orcid.org/0000-0001-7781-8802)
- Melanie C. Bois (ORCID: https://orcid.org/0000-0003-3093-3744)
- Larry M. Baddour (ORCID: https://orcid.org/0000-0002-4473-7077)
- Juan Andres Quintero-Martinez (ORCID: https://orcid.org/0000-0002-0785-9868)
- Supavit Chesdachai (ORCID: https://orcid.org/0000-0003-3507-6411)
Institutions
- Mayo Clinic (US)
- University of Miami (US)
- Jackson Memorial Hospital (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1093/ofid/ofaf179
- Citations
- 3
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.06